RecruitingPhase 2NCT07391605
Rare condition
Antisynthetase syndrome
5
studies recruiting now
as of 7 Sept 2026
15
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
20 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 1NCT07715136
BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
RecruitingNot applicableNCT07406932
A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome
RecruitingEarly phase 1NCT06613490
An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid Arthritis
RecruitingNCT03092180
Optimizing Treatment on Idiopathic Inflammatory Myopathies
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Antisynthetase syndrome studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Antisynthetase syndrome study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Antisynthetase syndrome
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).